Biotechnological and Biomedical Applications of Enzymes Involved in the Synthesis of Nucleosides and Nucleotides
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Enzymology".
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 24889
Special Issue Editor
Interests: biocatalysis; nucleoside analogues; bioinformatics; protein structure; enzyme immobilization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Purine and pyrimidine nucleotides are involved in a multitude of biochemical processes, but they are also particularly important as building blocks for RNA and DNA synthesis. Biosynthesis of nucleotides is performed through two different metabolic routes, de novo and salvage pathways. In the de novo pathway, purine nucleotides are synthesized from simple precursors like glycine, glutamine, or aspartate. In contrast, the salvage pathway employs nucleobases to generate the corresponding nucleoside-5´-monophosphates (NMPs). This requirement for nucleobases is satisfied by means of different endogenous and/or exogenous sources of preformed nitrogen bases. Both metabolic routes, de novo and salvage pathways, lead to the synthesis of NMPs, which are subsequently phosphorylated to get the corresponding nucleoside-5’-di (NMPs) and triphosphates (NTPs). Due to the importance of the enzymes involved in the synthesis of nucleosides and nucleotides, they have been extensively studied as potential targets for chemotherapy against different diseases or as important biocatalysts for the synthesis of different nucleoside and nucleotide analogs. This Special Issue will cover the most recent and relevant findings concerning biotechnological and biomedical applications of these enzymes, including (but not limited to) i) articles focused exclusively in the enzymatic or chemo-enzymatic synthesis of nucleic acid derivatives (NADs), ii) articles which cover new insights into the knowledge of these enzymes, and iii) articles focused on the use of these enzymes as therapeutic targets. In this sense, experimental and review articles from different areas, such as microbiology, molecular biology, biochemistry, biocatalysis, enzyme technology, genomics and proteomics, bioinformatics and protein engineering, among others, are welcome.
Dr. Jesús Fernandez Lucas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biotransformations
- biomedicine
- enzyme technology
- biochemistry
- organic chemistry